Unione Europea -
italiano -
EMA (European Medicines Agency)
phesgo
roche registration gmbh - pertuzumab, trastuzumab - neoplasie al seno - agenti antineoplastici - early breast cancer (ebc)phesgo is indicated for use in combination with chemotherapy in:the neoadjuvant treatment of adult patients with her2-positive, locally advanced, inflammatory, or early stage breast cancer at high risk of recurrencethe adjuvant treatment of adult patients with her2-positive early breast cancer at high risk of recurrencemetastatic breast cancer (mbc)phesgo is indicated for use in combination with docetaxel in adult patients with her2-positive metastatic or locally recurrent unresectable breast cancer, who have not received previous anti-her2 therapy or chemotherapy for their metastatic disease.
Unione Europea -
italiano -
EMA (European Medicines Agency)
evkeeza
ultragenyx germany gmbh - evinacumab - ipercolesterolemia - agenti modificanti i lipidi - evkeeza is indicated as an adjunct to diet and other low-density lipoprotein-cholesterol (ldl-c) lowering therapies for the treatment of adult and adolescent patients aged 12 years and older with homozygous familial hypercholesterolaemia (hofh).
Unione Europea -
italiano -
EMA (European Medicines Agency)
tecovirimat siga
siga technologies netherlands b.v. - tecovirimat - poxviridae infections; cowpox; monkeypox; vaccinia; smallpox - antivirali per uso sistemico - tecovirimat siga is indicated for the treatment of the following viral infections in adults and children with body weight at least 13 kg:- smallpox- monkeypox- cowpoxtecovirimat siga is also indicated to treat complications due to replication of vaccinia virus following vaccination against smallpox in adults and children with body weight at least 13 kg (see sections 4. 4 e 5. tecovirimat siga should be used in accordance with official recommendations.
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
cefaclor ratio. sosp fl 100ml
ratiopharm italia srl - cefacloro monoidrato - sospensione os - "250 mg/5 ml granulato per sospensione orale" flacone da 100 ml
Italia -
italiano -
AIFA (Agenzia Italiana del Farmaco)
metoprololo accord
accord healthcare, s.l.u. - metoprololo - metoprololo
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
imigran suppositorien
glaxosmithkline ag - sumatriptanum - suppositorien - sumatriptanum 25 mg, excipiens pro suppositorio. - akutbehandlung von migräneanfällen mit oder ohne aura - synthetika
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
sumatriptan-mepha injektionslösung
mepha pharma ag - sumatriptanum - injektionslösung - sumatriptanum 6 mg ut sumatriptani succinas (1:1), natrii chloridum, aqua ad iniectabilia q.s. ad solutionem pro 0.5 ml. - akutbehandlung von migräneanfällen mit oder ohne aura und cluster headache - synthetika human
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
sumatriptan-mepha 50 lactab
mepha pharma ag - sumatriptanum - lactab - sumatriptanum 50 mg ut sumatriptani succinas (1:1), carmellosum natricum conexum, excipiens pro compresso obducto. - akutbehandlung von migräneanfällen mit oder ohne aura - synthetika human
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
sumatriptan-mepha t 50 lactab
mepha pharma ag - sumatriptanum - lactab - sumatriptanum 50 mg ut sumatriptani succinas (1:1), carmellosum natricum conexum, excipiens pro compresso obducto. - akutbehandlung von migräneanfällen mit oder ohne aura - synthetika human
Svizzera -
italiano -
Swissmedic (Swiss Agency for Therapeutic Products)
sumatriptan spirig hc filmtabletten
spirig healthcare ag - sumatriptanum - filmtabletten - sumatriptanum 50 mg ut sumatriptani succinas (1:1), excipiens pro compresso obducto. - akutbehandlung von migräneanfällen mit oder ohne aura - synthetika human